Ziming Du

1.7k total citations
32 papers, 1.0k citations indexed

About

Ziming Du is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Ziming Du has authored 32 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 10 papers in Oncology and 7 papers in Epidemiology. Recurrent topics in Ziming Du's work include Epigenetics and DNA Methylation (6 papers), Glioma Diagnosis and Treatment (5 papers) and Meningioma and schwannoma management (4 papers). Ziming Du is often cited by papers focused on Epigenetics and DNA Methylation (6 papers), Glioma Diagnosis and Treatment (5 papers) and Meningioma and schwannoma management (4 papers). Ziming Du collaborates with scholars based in China, United States and Sweden. Ziming Du's co-authors include Sandro Santagata, David A. Reardon, Jia‐Ren Lin, Peter K. Sorger, Ian F. Dunn, Tingfeng Wu, Malak Abedalthagafi, Youxin Zhou, Zhenhua Wu and Xiaolei Li and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Ziming Du

32 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ziming Du China 17 484 303 280 234 215 32 1.0k
Robert T. Jones United States 8 513 1.1× 154 0.5× 510 1.8× 168 0.7× 380 1.8× 20 1.2k
Maxwell W. Tom United States 10 493 1.0× 177 0.6× 118 0.4× 407 1.7× 131 0.6× 10 975
Valérie Panet-Raymond Canada 16 306 0.6× 220 0.7× 289 1.0× 474 2.0× 306 1.4× 50 1.4k
Emma Tham Sweden 19 470 1.0× 373 1.2× 237 0.8× 53 0.2× 359 1.7× 59 1.2k
Isabella Morra Italy 19 412 0.9× 293 1.0× 204 0.7× 266 1.1× 296 1.4× 43 1.2k
Lindsey M. Hoffman United States 20 432 0.9× 134 0.4× 115 0.4× 558 2.4× 255 1.2× 60 1.1k
Genevieve Schindler Germany 6 605 1.3× 207 0.7× 143 0.5× 776 3.3× 231 1.1× 8 1.3k
Isabelle Nanni France 17 310 0.6× 206 0.7× 163 0.6× 245 1.0× 362 1.7× 32 996
Gautam U. Mehta United States 18 130 0.3× 237 0.8× 284 1.0× 221 0.9× 202 0.9× 86 1.2k
Oskar Koperek Austria 24 299 0.6× 143 0.5× 271 1.0× 154 0.7× 314 1.5× 44 1.3k

Countries citing papers authored by Ziming Du

Since Specialization
Citations

This map shows the geographic impact of Ziming Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ziming Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ziming Du more than expected).

Fields of papers citing papers by Ziming Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ziming Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ziming Du. The network helps show where Ziming Du may publish in the future.

Co-authorship network of co-authors of Ziming Du

This figure shows the co-authorship network connecting the top 25 collaborators of Ziming Du. A scholar is included among the top collaborators of Ziming Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ziming Du. Ziming Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wen, Lei, Yuting Lu, Zhigang Chen, et al.. (2024). Clinical and molecular characteristics of RNF43 mutations as promising prognostic biomarkers in colorectal cancer. Therapeutic Advances in Medical Oncology. 16. 2665336–2665336. 2 indexed citations
2.
Yang, Jiaojiao, Yuxia Xu, Weijie Zhu, et al.. (2023). Targeted demethylation of the CDO1 promoter based on CRISPR system inhibits the malignant potential of breast cancer cells. Clinical and Translational Medicine. 13(9). e1423–e1423. 11 indexed citations
3.
Tang, Wenting, et al.. (2022). Alpha-Fetoprotein Ratio Predicts Alpha-Fetoprotein Positive Hepatocellular Cancer Patient Prognosis after Hepatectomy. Disease Markers. 2022. 1–9. 2 indexed citations
4.
He, Wenting, Yi Guo, Yuanzhong Wu, et al.. (2022). Targeted demethylation at ZNF154 promotor upregulates ZNF154 expression and inhibits the proliferation and migration of Esophageal Squamous Carcinoma cells. Oncogene. 41(40). 4537–4546. 13 indexed citations
5.
Chen, Xiaoxi, Zhigang Chen, Chao Ren, et al.. (2022). Monitoring tumour resistance to the BRAF inhibitor combination regimen in colorectal cancer patients via circulating tumour DNA. Drug Resistance Updates. 65. 100883–100883. 20 indexed citations
6.
Du, Ziming, Yuying Liu, Yanhong Li, et al.. (2021). Diagnostic and Prognostic Characteristics of Circulating Free DNA Methylation Detected by the Electrochemical Method in Malignant Tumors. Cancers. 13(4). 664–664. 2 indexed citations
7.
Meißner, Torsten, Fang Wang, Ziming Du, et al.. (2021). ELF3 activated by a superenhancer and an autoregulatory feedback loop is required for high-level HLA-C expression on extravillous trophoblasts. Proceedings of the National Academy of Sciences. 118(9). 17 indexed citations
8.
Chen, Xiuxing, Ziming Du, De‐Shen Wang, et al.. (2021). Circulating PD-L1 is associated with T cell infiltration and predicts prognosis in patients with CRLM following hepatic resection. Cancer Immunology Immunotherapy. 71(3). 661–674. 21 indexed citations
9.
Ji, Xiaomeng, Chao Ren, Zhi‐Qiang Wang, et al.. (2021). The Prognostic Value of Locoregional Interventions for BRAF V600E Metastatic Colorectal Cancer: A Retrospective Cohort Analysis. Biomolecules. 11(9). 1268–1268. 3 indexed citations
10.
Rashid, Rumana, Giorgio Gaglia, Chen Yuan, et al.. (2019). Highly multiplexed immunofluorescence images and single-cell data of immune markers in tonsil and lung cancer. Scientific Data. 6(1). 323–323. 26 indexed citations
11.
Du, Ziming, Jia‐Ren Lin, Rumana Rashid, et al.. (2019). Qualifying antibodies for image-based immune profiling and multiplexed tissue imaging. Nature Protocols. 14(10). 2900–2930. 72 indexed citations
12.
Dunn, Ian F., Ziming Du, Mehdi Touat, et al.. (2018). Mismatch Repair Deficiency in High-Grade Meningioma: A Rare but Recurrent Event Associated With Dramatic Immune Activation and Clinical Response to PD-1 Blockade. JCO Precision Oncology. 2018(2). 1–12. 51 indexed citations
13.
Feng, Mei, et al.. (2018). Novel lncRNA-ZNF281 regulates cell growth, stemness and invasion of glioma stem-like U251s cells. Neoplasma. 66(1). 118–127. 19 indexed citations
14.
Mei, Yu, Ziming Du, Changchen Hu, et al.. (2017). Osteoglycin promotes meningioma development through downregulation of NF2 and activation of mTOR signaling. Cell Communication and Signaling. 15(1). 34–34. 32 indexed citations
15.
Han, Yong, Zhenhua Wu, Tingfeng Wu, et al.. (2016). Tumor-suppressive function of long noncoding RNA MALAT1 in glioma cells by downregulation of MMP2 and inactivation of ERK/MAPK signaling. Cell Death and Disease. 7(3). e2123–e2123. 187 indexed citations
16.
Coy, Shannon, Ziming Du, Shu‐Hsien Sheu, et al.. (2016). Distinct patterns of primary and motile cilia in Rathke's cleft cysts and craniopharyngioma subtypes. Modern Pathology. 29(12). 1446–1459. 16 indexed citations
17.
Abedalthagafi, Malak, Wenya Linda Bi, Parker Merrill, et al.. (2015). ARID1A and TERT promoter mutations in dedifferentiated meningioma. Cancer Genetics. 208(6). 345–350. 63 indexed citations
18.
Du, Ziming, Malak Abedalthagafi, Ayal A. Aizer, et al.. (2014). Increased expression of the immune modulatory molecule PD-L1 (CD274) in anaplastic meningioma. Oncotarget. 6(7). 4704–4716. 126 indexed citations
19.
Du, Ziming, Haiyun Wang, Jing Chen, et al.. (2012). Clinical significance of elevated spleen tyrosine kinase expression in nasopharyngeal carcinoma. Head & Neck. 34(10). 1456–1464. 7 indexed citations
20.
Du, Ziming, Chunfang Hu, Qiong Shao, et al.. (2009). Upregulation of caveolin‐1 and CD147 expression in nasopharyngeal carcinoma enhanced tumor cell migration and correlated with poor prognosis of the patients. International Journal of Cancer. 125(8). 1832–1841. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert T. Jones Breakdown of academic impact, for papers by Maxwell W. Tom Breakdown of academic impact, for papers by Valérie Panet-Raymond Breakdown of academic impact, for papers by Emma Tham Breakdown of academic impact, for papers by Isabella Morra Breakdown of academic impact, for papers by Lindsey M. Hoffman Breakdown of academic impact, for papers by Genevieve Schindler Breakdown of academic impact, for papers by Isabelle Nanni Breakdown of academic impact, for papers by Gautam U. Mehta Breakdown of academic impact, for papers by Oskar Koperek
Rankless by CCL
2026